SMAD1 and neurodegenerative disease: Therefore, as the pathology progresses in both human samples and mouse models, the expression of SMAD1, -5, -8 mRNA, and protein increases in neurodegenerative diseases, suggesting that these changes can be used as disease progression markers [16].